Significantly Lower Anti-Leishmania IgG Responses in Sudanese versus Indian Visceral Leishmaniasis

PLoS Neglected Tropical Diseases

Volumn 8, Issue 2, 2014, Pages

  Bhattacharyya, Tapan ^a   Bowes, Duncan E ^a   El Safi, Sayda ^b   Sundar, Shyam ^c   Falconar, Andrew K ^d   Singh, Om Prakash ^c   Kumar, Rajiv ^c,e   Ahmed, Osman ^b,f   Boelaert, Marleen ^g   Miles, Michael A ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c BANARAS HINDU UNIVERSITY   (India)

^d UNIVERSIDAD DEL NORTE   (Colombia)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^f KAROLINSKA INSTITUTE   (Sweden)

^g INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PARASITE ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNIC GROUP; FEMALE; HUMAN; INDIAN; LEISHMANIA DONOVANI; MAJOR CLINICAL STUDY; MALE; SUDAN; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOCHROMATOGRAPHY; IMMUNOGLOBULIN G; INDIA; INFANT; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; SUDAN; YOUNG ADULT;

EID: 84895766222     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002675     Document Type: Article

References (57)

1. Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, et al. (2012) Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7: e35671.
2. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, et al. (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5: 873-882.
3. Srivastava P, Dayama A, Mehrotra S, Sundar S, (2011) Diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 105: 1-6.
4. Oliveira E, Saliba SW, Saliba JW, Rabello A, (2013) Validation of a direct agglutination test prototype kit for the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 107: 243-247.
5. Burns JM Jr, Shreffler WG, Benson DR, Ghalib HW, Badaro R, et al. (1993) Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A 90: 775-779.
6. Boelaert M, El-Safi S, Hailu A, Mukhtar M, Rijal S, et al. (2008) Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg 102: 32-40.
7. Cunningham J, Hasker E, Das P, El Safi S, Goto H, et al. (2012) A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis 55: 1312-1319.
8. Pattabhi S, Whittle J, Mohamath R, El-Safi S, Moulton GG, et al. (2010) Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis. PLoS Negl Trop Dis 4: e822.
9. Vaish M, Bhatia A, Reed SG, Chakravarty J, Sundar S, (2012) Evaluation of rK28 antigen for serodiagnosis of visceral Leishmaniasis in India. Clin Microbiol Infect 18: 81-85.
10. Bhattacharyya T, Boelaert M, Miles MA, (2013) Comparison of visceral leishmaniasis diagnostic antigens in African and Asian Leishmania donovani reveals extensive diversity and region-specific polymorphisms. PLoS Negl Trop Dis 7: e2057.
11. Nolder D, Roncal N, Davies CR, Llanos-Cuentas A, Miles MA, (2007) Multiple hybrid genotypes of Leishmania (viannia) in a focus of mucocutaneous Leishmaniasis. Am J Trop Med Hyg 76: 573-578.
12. Falconar AK, de Plata E, Romero-Vivas CM, (2006) Altered enzyme-linked immunosorbent assay immunoglobulin M (IgM)/IgG optical density ratios can correctly classify all primary or secondary dengue virus infections 1 day after the onset of symptoms, when all of the viruses can be isolated. Clin Vaccine Immunol 13: 1044-1051.
13. Falconar AK, Romero-Vivas CM, (2012) Simple Prognostic Criteria can Definitively Identify Patients who Develop Severe Versus Non-Severe Dengue Disease, or Have Other Febrile Illnesses. J Clin Med Res 4: 33-44.
14. Ghasemi A, Zahediasl S, (2012) Normality tests for statistical analysis: a guide for non-statisticians. Int J Endocrinol Metab 10: 486-489.
15. World Health Organization (2012) Research Priorities for Chagas Disease, Human African Trypanosomiasis and Leishmaniasis. Geneva, Switzerland: World Health Organization.
16. Abass E, Bollig N, Reinhard K, Camara B, Mansour D, et al. (2013) rKLO8, a Novel Leishmania donovani- Derived Recombinant Immunodominant Protein for Sensitive Detection of Visceral Leishmaniasis in Sudan. PLoS Negl Trop Dis 7: e2322.
17. Tatemichi M, Hamada GS, Nishimoto IN, Kowalski LP, Iriya K, et al. (2003) Ethnic difference in serology of Helicobacter pylori CagA between Japanese and non-Japanese Brazilians for non-cardia gastric cancer. Cancer Sci 94: 64-69.
18. Yang LP, Eriksson BK, Harrington Z, Curtis N, Lang S, et al. (2006) Variations in the protective immune response against streptococcal superantigens in populations of different ethnicity. Med Microbiol Immunol 195: 37-43.
19. Modiano D, Chiucchiuini A, Petrarca V, Sirima BS, Luoni G, et al. (1999) Interethnic differences in the humoral response to non-repetitive regions of the Plasmodium falciparum circumsporozoite protein. Am J Trop Med Hyg 61: 663-667.
20. Lourembam SD, Baruah S, (2012) Antibody response to allelic variants of 19kDa fragment of MSP-1: recognition of a variant and protection associated with ethnicity in Assam, India. Vaccine 30: 767-773.
21. Jensen JB, Hoffman SL, Boland MT, Akood MA, Laughlin LW, et al. (1984) Comparison of immunity to malaria in Sudan and Indonesia: crisis-form versus merozoite-invasion inhibition. Proc Natl Acad Sci U S A 81: 922-925.
22. Fischbacher CM, Bhopal R, Blackwell CC, Ingram R, Unwin NC, et al. (2003) IgG is higher in South Asians than Europeans: does infection contribute to ethnic variation in cardiovascular disease? Arterioscler Thromb Vasc Biol 23: 703-704.
23. Maia Z, Lirio M, Mistro S, Mendes CM, Mehta SR, et al. (2012) Comparative study of rK39 Leishmania antigen for serodiagnosis of visceral leishmaniasis: systematic review with meta-analysis. PLoS Negl Trop Dis 6: e1484.
24. Abeijon C, Campos-Neto A, (2013) Potential Non-invasive Urine-Based Antigen (Protein) Detection Assay to Diagnose Active Visceral Leishmaniasis. PLoS Negl Trop Dis 7: e2161.
25. Sundar S, Agrawal S, Pai K, Chance M, Hommel M, (2005) Detection of leishmanial antigen in the urine of patients with visceral leishmaniasis by a latex agglutination test. Am J Trop Med Hyg 73: 269-271.
26. Attar ZJ, Chance ML, el-Safi S, Carney J, Azazy A, et al. (2001) Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Trop 78: 11-16.
27. Sarkari B, Chance M, Hommel M, (2002) Antigenuria in visceral leishmaniasis: detection and partial characterisation of a carbohydrate antigen. Acta Trop 82: 339-348.
28. Alam M, Shamsuzzaman A, Musa A, Khan A, Mahmud M, et al. (2008) Antigen detection from urine of Kala-azar cases by latex agglutination test. Mymensingh Med J 17: 22-27.
29. Ahsan MM, Islam MN, Mollah AH, Hoque MA, Hossain MA, et al. (2010) Evaluation of latex agglutination test (KAtex) for early diagnosis of kala-azar. Mymensingh Med J 19: 335-339.
30. Salam MA, Khan MG, Mondal D, (2011) Urine antigen detection by latex agglutination test for diagnosis and assessment of initial cure of visceral leishmaniasis. Trans R Soc Trop Med Hyg 105: 269-272.
31. Zijlstra EE, Musa AM, Khalil EAG, El Hassan IM, El-Hassan AM, (2003) Post-kala-azar dermal leishmaniasis. The Lancet Infectious Diseases 3: 87-98.
32. Nylen S, Sacks D, (2007) Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol 28: 378-384.
33. Liu L, Wang L, Zhao Y, Wang Y, Wang Z, et al. (2006) Testosterone attenuates p38 MAPK pathway during Leishmania donovani infection of macrophages. Parasitol Res 99: 189-193.
34. Ritmeijer K, Davidson RN, (2003) Royal Society of Tropical Medicine and Hygiene joint meeting with Medecins Sans Frontieres at Manson House, London, 20 March 2003: field research in humanitarian medical programmes. Medecins Sans Frontieres interventions against kala-azar in the Sudan, 1989-2003. Trans R Soc Trop Med Hyg 97: 609-613.
35. Seaman J, Mercer AJ, Sondorp E, (1996) The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol 25: 862-871.
36. Ibrahim ME, Lambson B, Yousif AO, Deifalla NS, Alnaiem DA, et al. (1999) Kala-azar in a high transmission focus: an ethnic and geographic dimension. Am J Trop Med Hyg 61: 941-944.
37. Moszynski P, (2010) Kala-azar outbreak is symptomatic of humanitarian crisis facing southern Sudan. BMJ 341: c7276.
38. Pantuliano S, (2007) From food aid to livelihoods support: rethinking the role of WFP in eastern Sudan. Disasters 31Suppl 1: S77-90.
39. Mahgoub HM, Adam I, (2012) Morbidity and mortality of severe malnutrition among Sudanese children in New Halfa Hospital, Eastern Sudan. Trans R Soc Trop Med Hyg 106: 66-68.
40. Bucheton B, Kheir MM, El-Safi SH, Hammad A, Mergani A, et al. (2002) The interplay between environmental and host factors during an outbreak of visceral leishmaniasis in eastern Sudan. Microbes Infect 4: 1449-1457.
41. Bucheton B, Abel L, El-Safi S, Kheir MM, Pavek S, et al. (2003) A major susceptibility locus on chromosome 22q12 plays a critical role in the control of kala-azar. Am J Hum Genet 73: 1052-1060.
42. Hughes S, Kelly P, (2006) Interactions of malnutrition and immune impairment, with specific reference to immunity against parasites. Parasite Immunol 28: 577-588.
43. Soong L, (2012) Subversion and Utilization of Host Innate Defense by Leishmania amazonensis. Front Immunol 3: 58.
44. Serafim TD, Malafaia G, Silva ME, Pedrosa ML, Rezende SA, (2010) Immune response to Leishmania (Leishmania) chagasi infection is reduced in malnourished BALB/c mice. Mem Inst Oswaldo Cruz 105: 811-817.
45. Anstead GM, Chandrasekar B, Zhao W, Yang J, Perez LE, et al. (2001) Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infect Immun 69: 4709-4718.
46. Shankar AH, Prasad AS, (1998) Zinc and immune function: the biological basis of altered resistance to infection. Am J Clin Nutr 68: 447S-463S.
47. Gaffen SL, Liu KD, (2004) Overview of interleukin-2 function, production and clinical applications. Cytokine 28: 109-123.
48. Poland GA, Ovsyannikova IG, Jacobson RM, (2009) Application of pharmacogenomics to vaccines. Pharmacogenomics 10: 837-852.
49. Dhiman N, Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, et al. (2008) Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens 72: 211-220.
50. Bucheton B, Argiro L, Chevillard C, Marquet S, Kheir MM, et al. (2007) Identification of a novel G245R polymorphism in the IL-2 receptor beta membrane proximal domain associated with human visceral leishmaniasis. Genes Immun 8: 79-83.
51. Shiina T, Hosomichi K, Inoko H, Kulski JK, (2009) The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet 54: 15-39.
52. Mangalam AK, Taneja V, David CS, (2013) HLA class II molecules influence susceptibility versus protection in inflammatory diseases by determining the cytokine profile. J Immunol 190: 513-518.
53. Trowsdale J, Knight JC, (2013) Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet 14: 301-323.
54. Meddeb-Garnaoui A, Gritli S, Garbouj S, Ben Fadhel M, El Kares R, et al. (2001) Association analysis of HLA-class II and class III gene polymorphisms in the susceptibility to mediterranean visceral leishmaniasis. Hum Immunol 62: 509-517.
55. Peacock CS, Sanjeevi CB, Shaw MA, Collins A, Campbell RD, et al. (2002) Genetic analysis of multicase families of visceral leishmaniasis in northeastern Brazil: no major role for class II or class III regions of HLA. Genes Immun 3: 350-358.
56. Leish GENC, Wellcome Trust Case Control C, Fakiola M, Strange A, Cordell HJ, et al. (2013) Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. Nat Genet 45: 208-213.
57. Kuhls K, Alam MZ, Cupolillo E, Ferreira GE, Mauricio IL, et al. (2011) Comparative microsatellite typing of new world leishmania infantum reveals low heterogeneity among populations and its recent old world origin. PLoS Negl Trop Dis 5: e1155.